ABOUT Servier (Ireland) Industries Ltd.
Servier Arklow is the largest production facility outside France for the Servier Group.
About us
Located on a magnificent 60 acre site just outside Arklow, Co. Wicklow, Servier (Ireland) Industries Ltd. was established in 1989 with just 12 staff.
Over 35 years later our beautiful architecturally designed pharmaceutical manufacturing plant, whilst always maintaining its unique style, has grown and is now home to approximately 500 staff.
It is the second largest site in the Servier Group network. Focusing on three therapeutic areas – oncology, cardiometabolism & venous diseases, neurology – we export to 100 above countries and are committed to providing patients with quality medicines.
60
acres
(24 hectares)
500+
Employees
10
Departments
160+
million Boxes produced annually
Supplying 100
countries worldwide
OUR THERAPEUTIC AREAS
Servier invests close to 20% of its brand-name revenue in Research and Development every year.
To maximise the success of its therapeutic innovations while also preserving the specificities inherent to their development, Servier has chosen to channel its efforts in four therapeutic fields.
OUR PRODUCTS
A leader in cardiology, the ambition of the Servier Group is to become a renowned and innovative player in oncology. Its growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology and immuno-inflammatory, and neuropsychiatric diseases.
Our activity
The Arklow site produces oral solid dose tablets. Our products are predominantly prescription medicines and are packed in Bottle, Blister and Bulk formats.
Our manufacturing process is as follows:
“As the General Manager of Servier Arklow, I am pleased to reaffirm our unwavering commitment to excellence and patient care. At Servier, we prioritise quality and safety, ensuring our products meet the highest standards. Innovation drives us to develop new treatments that address unmet medical needs, while our patient-centric approach ensures we always put patients first.
We uphold the highest ethical standards in all our practices, maintaining transparency and integrity. Additionally, we are dedicated to sustainability, striving to reduce our environmental impact and support our communities. We work towards our 2030 ambition, to accelerate our transformation. Patient 1st, Safety Always.”
Pascal Baraffe, General Manager